Concr
PrivateLast Round
Grant
Feb 9, 2024
Total Funding Raised
$2.46M
Momentum Score
25 /100
Company Overview
Concr is a techbio company that provides a predictive modelling platform, FarrSight®, to enhance confidence and foresight about the therapeutic efficacy of existing and emerging cancer drugs.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Medical AI, Clinical Trials, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Concr Comps
Public and private peers based on sector, stage, and business model.
Concr Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 9, 2024 | ||||
| Seed | Nov 29, 2023 |
Key People
Founding team and executive leadership
Concr Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Cambridge Angels | Seed |
| Cambridge Enterprise | Seed |
| Debiopharm Innovation Fund | Seed |
| R42 Group | Seed |
| Parkwalk Advisors | Seed |
Concr Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Concr's valuation, stock price, and market status.
